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Abstract
Background: Culture contamination with environmental bacteria is a major challenge in tuberculosis (TB)
laboratories in hot and humid climate zones. We studied the effect of cetylpyridinium chloride (CPC) preservation
on culture results and performance of Xpert MTB/RIF.
Methods: Consecutive sputum samples from microscopy smear-positive TB patients were collected. Two-hundred
samples were equally split in two aliquots, one aliquot was treated with CPC and stored at ambient temperature for
7 days. The second aliquot was immediately processed. Samples were decontaminated for 20, 15 or 10 min, and
subsequently cultured on Löwenstein-Jensen medium. Furthermore, 50 samples were stored for 7, 14 and 21 days,
and 100 CPC-pretreated samples tested by Xpert MTB/RIF.
Results: CPC pretreated samples showed a higher culture yield compared to non-treated sputum samples across
all decontamination times: 94% vs. 73% at 10 min (p = 0.01), 94% vs. 64% at 15 min (p = 0.004), and 90% vs. 52% at
20 min (p < 0.001). The quantitative culture grading was consistently higher in CPC treated compared to non-CPC
treated samples. The proportion of contaminated cultures was lower in CPC pretreated samples across all
decontamination times (range 2-6%) compared to non-CPC treated samples (15-16%). For storage times of CPC
treated samples of 7, 14, and 21 days, 84, 86, and 84% of the respective cultures were positive. Of 91 CPC treated
samples with a positive culture, 90 were also Xpert MTB/RIF positive.
Conclusions: CPC increases culture yield, decreases the proportion of contamination, and does not alter the
performance of Xpert MTB/RIF.
Keywords: Mycobacterium tuberculosis, Tuberculosis, Cetylpyridinium chloride, CPC, Sample transport, Preservation,
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Background
Tanzania is among the 30 countries with the highest tu-
berculosis (TB) burden worldwide according to the
World Health Organization (WHO), with 63,151 TB
cases in 2015 [1]. Of these, 60,563 were new cases, and
1580 were previously treated [1]. Retreatment cases are
of particular concern to public health due to the failure
of treatment with first-line drugs that makes it crucial to
closely monitor TB cases, which includes drug suscepti-
bility testing (DST) performed by a TB laboratory. In
Tanzania, the central tuberculosis referral laboratory
(CTRL) is responsible to perform DST nationwide. DST
relies in turn on sputum samples, but these often do not
reach the CTRL or, when they do, samples show over-
growth with other bacteria such as nontuberculous
mycobacteria from the environment or commensal bac-
teria from the airways [2, 3]. To correctly identify a posi-
tive sputum sample, viability must be preserved and
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contamination with environmental and commensal bac-
teria suppressed during transportation [4, 5]. Cetylpyri-
dinium chloride (CPC) with sodium chloride is a simple
reagent with low toxicity to Mycobacterium tuberculosis
that has a mild decontamination effect on bacteria and
fungi [6]. The use of Difco neutralization buffer with
CPC treated samples before inoculation has been ob-
served to further increase the culture yield [7].
Though CPC can preserve sample viability and reduce
contamination, which makes it an effective reagent for
storage of sputum samples at ambient temperature for
several days [6, 8], rigorous evaluation of the effect of CPC
treatment on culture and molecular test performance has
been limited in sub-Saharan Africa. We aimed to
systematically study the effect of CPC treatment and
decontamination time on culture results compared to
non-CPC samples, tested if the use of Difco neutralization
buffer with CPC treated samples before inoculation can
further increase the culture yield, and investigated the
performance of Xpert MTB/RIF in CPC treated samples.
Methods
Study setting and study procedures
We included 200 sputum samples prospectively collected
from an ongoing cohort study of adult smear-positive TB
patients (≥18 years) in Dar es Salaam, Tanzania (TB-DAR).
Consecutive sputum samples with a volume of >4 mL
were transported daily from the TB clinic in Dar es
Salaam to the TB laboratory in Bagamoyo (Ifakara
Health Institute, Tanzania) using temperature-controlled
cooling boxes (4-8 °C), because proper procedures of spu-
tum homogenization and splitting into two aliquots were
not possible on site. Sputum microscopy was performed
on site using fluorescent light-emitting diode (LED) mi-
croscopy, and the quantitative scoring system was based
on the number of acid-fast bacilli (AFB) according to the
national guideline [9]. Sputum smear-positivity was de-
fined as at least scanty on the quantitative grading system.
Sputum sample processing
The sample processing at the TB laboratory is summarized
in Fig. 1.
Sputum homogenization and splitting into two aliquots
Sputum samples (>4 mL volume) from the TB clinic
were homogenized using sterile Pasteur pipettes and
split into two 2 mL aliquots, each in a 50 ml sterile
Falcon tube (Fisher Scientific, Switzerland).
CPC processing and decontamination of CPC treated
samples (first aliquot)
The first aliquot of the same sample was treated with 1%
CPC (1:1 CPC and sample), mixed thoroughly using a
vortex mixer until an even solution was observed, then
Samples (>4 mL) from 200 smear-positive TB patients in Temeke:
n=200
Samples transported in cooler boxes (4° C) to the TB Laboratory in Bagamoyo
Samples were divided into two equal aliquots: 
n=2x200
One aliquot processed immediately 
(non-CPC): 
n=200
One aliquot treated with CPC, stored at 
RT (25°C) for 7 days:
n=200
Routine 1.5% NALC-NaOH
decontamination for 20 min
100 random samples 
for GeneXpert
MTB/RIF
Inoculation on Lowenstein-Jensen media at 37°C for up to 8 weeks, confirmation 
by ZN, and WHO grading of culture results
50 samples were 
incubated in CPC for 
















Fig. 1 Overview of sputum sample processing. Cetylpyridinium chloride (CPC); Difco buffer, Difco neutralizing buffer; RT, room temperature; TB,
tuberculosis; ZN, Ziehl-Nielsen staining. 1 1% NaOH decontamination
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incubated at 25 °C for 7, 14, or 21 days before decontamin-
ation. The CPC solution was prepared according to the
manufacturer’s instruction (Sigma-Aldrich, Switzerland).
Following the CPC incubation, samples were deconta-
minated using 2% NaOH, with 1% NaOH as the final
concentration.
For the samples incubated for 7 days we used three dif-
ferent decontamination durations of 10, 15, and 20 min.
The decontamination time of the samples incubated for
further 14 and 21 days was 15 min.
Decontamination of non-CPC samples (second aliquot)
The second aliquot containing native sputum was immedi-
ately processed by adding 3% NaOH with 0.4 g of N-
acetyl-L-cysteine (NALC), with a 1.5% final concentration
of NaOH. The aliquot was digested for 20 min at room
temperature (25 °C). Processing was stopped with pH 6.7
phosphate buffer solution (PBS). The mixture was then
centrifuged at 4 °C at 3000 g for 20 min to obtain a con-
centrated pellet, which was reconstituted with three drops
of PBS solution and which was directly inoculated on
Lowenstein-Jensen (LJ) slants. Cultures were incubated for
up to 8 weeks at 37 °C and observed weekly for growth.
Addition of neutralization buffer
In 50 samples treated for CPC during 7 days (optimal
decontamination time, Table 1), after decontamination a
Difco neutralizing buffer (Beckton Dickson, USA) was
added instead of PBS buffer. The Difco buffer (contain-
ing monopotassium phosphate, sodium thiosulfate, and
aryl sulfonate complex) was used to halt further reaction
of NaOH and for the resuspension of the pellet. The
buffer was prepared by dissolving 5.2 g of Difco powder
in 1 L of sterile water and the solution was autoclaved at
121 °C for 15 min. The final buffer pH was 7.2. Difco
buffer solution was added up to the 50 mL mark on the
falcon tube, and the mixture was centrifuged at 4 °C at
3000 g for 20 min to obtain a concentrated pellet, which
was reconstituted with three drops of Difco solution and
which was inoculated on LJ slants. Cultures were incubated
for up to 8 weeks at 37 °C and observed weekly for growth.
Mycobacterial cultures
All decontaminated samples were inoculated on the LJ
media, incubated at 37 °C and observed for 8 weeks for
any growth, with culture grading using the WHO system
of <20 colonies, 1+, 2+, 3+ for positive, negative, and
contamination. All LJ slants were read every week to
observe culture growth.
Xpert MTB/RIF testing
For the molecular analysis, 100 CPC treated and deconta-
minated pellets were randomly selected and tested using
the Xpert MTB/RIF assay (Cepheid, USA), in which
0.5 mL of CPC stored pellet was added to 1.5 mL of Xpert
buffer. Tubes were vortexed and incubated for 10 min at
room temperature, vortexed again and incubated further
for 5 min. The suspension was then transferred to the
Xpert cartridge and loaded into the Xpert MTB/RIF
machine for the analysis of the sample. Results were read
and printed two hours after initiating the assay.
Data analysis
We used descriptive statistics to present the results.
The Fisher’s exact test was applied to test the statis-
tical significance of the observed differences in CPC
treated and non-CPC samples with different decontamin-
ation times (20, 15 and 10 min), and different CPC incu-
bation times (non-CPC, CPC incubation of 7, 14, and
21 days). All analyses were performed in Stata version 14
(Texas, USA).
Table 1 Effect of decontamination time on culture results in cetylpyridinium chloride (CPC) treated and non-CPC samples from
tuberculosis (TB) patients in Tanzania
Culture grading
(WHO)
Decontamination of CPC treated samples, n (%)
20 min1 15 min2 10 min3
Non-CPC CPC Non-CPC CPC Non-CPC CPC
Contaminated 7 (14) 1 (2) 8 (16) 1 (2) 7 (14) 0 (0)
Negative 17 (34) 4 (8) 8 (16) 2 (4) 6 (12) 3 (6)
Positive 26 (52) 45 (90) 34 (64) 47 (94) 37 (74) 47 (94)
< 20 colonies 2 (4) 3 (6) 2 (4) 2 (4) 0 (0) 0 (0)
1+ 5 (10) 7 (14) 11(22) 9 (18) 4 (8) 7 (14)
2+ 10 (20) 17 (34) 11 (22) 18(36) 12(24) 15 (30)
3+ 9(18) 18 (36) 10 (20) 18 (36) 21(42) 25 (50)
Total 50 (100) 50 (100) 50 (100) 50 (100) 50 (100) 50 (100)
Difference between CPC treated samples and non-CPC according to WHO culture grading (contaminated, negative, positive): p < 0.0011, p = 0.0042, and
p = 0.0073, respectively (Fisher’s exact test)
Culture results of 150 sputum samples split into two equal aliquots, one of which was treated with CPC before processing, with varying times of decontamination
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Results
Culture performance of CPC treated and non-CPC samples
Effect of CPC treatment and decontamination time on
culture recovery
We analyzed 200 samples split in two equal aliquots
(2 × 200, Fig. 1), and each treated with or without CPC.
Comparing CPC treated with non-CPC samples, we ob-
served a culture positivity of 90% vs. 52% for the 20-min
decontamination time (p < 0.001), 94% vs. 64% for the
15-min decontamination time (p = 0.004), and 94% vs.
74% for the 10-min decontamination time (p = 0.007),
as shown in Table 1. Contamination rates were 2% vs
14% for the 20 -min decontamination time, 2% vs 16%
for the 15-min decontamination time, and 0% vs 14% for
10-min decontamination time (Table 1). The 15-min
decontamination showed a low negativity of 4% and the
contamination rate was 2% (Table 1).
Effect of the duration of CPC treatment on culture recovery
The effect of CPC treatment on culture recovery was
examined in 50 sputum samples at three intervals lasting
7, 14, and 21 days (Fig. 1). Culture recovery was 84% (42
samples), 86% (43), and 82% (41) respectively (Table 2).
The contamination proportion at the same time intervals
was 12% (6 samples), 12% (6), and 6% (3), respectively.
Effect of neutralization buffer on culture recovery
In 50 samples, each with two aliquots (2 × 50, Fig. 1),
following 7 days of CPC treatment, the Difco buffer did
not yield higher culture recovery than the phosphate
buffer solution. Recovery was 42/50 (84%) with Difco,
and 45/50 (90%) with PBS.
Performance of Xpert MTB/RIF in CPC treated samples
Of 100 CPC treated samples, 97 were Xpert-positive and
three were Xpert-negative (Table 3). Of the 91 culture-
positive samples, 90 were Xpert-positive and one Xpert-
negative (sensitivity: 98.9%, 95% confidence interval [CI]
94-100%). Of the six culture-negative samples, four were
Xpert-positive and two Xpert-negative. All contaminated
samples were Xpert-positive (Table 3).
Discussion
Our study conducted in the high TB incidence country
Tanzania using 200 samples, equally split into a CPC
and non-CPC study arm, showed that preservation of
sputum samples in CPC increases the TB culture yield
and decreases contamination, and that CPC pretreat-
ment has no negative effect on the performance of
Xpert MTB/RIF.
Sputum samples can lose viability during long-duration
transportation over large distances, which increases con-
tamination by environmental and commensal bacteria
present in the sputum and suppresses growth of TB [6, 10].
CPC is known to be an effective sputum transportation re-
agent, which decreases contamination by microflora during
transportation. However, this has been reported only in
studies outside of sub-Saharan Africa [5, 10–12]. Sub-
Saharan African countries like Tanzania have a distinct hot
and humid climate with a high chance of environmental
bacteria to contaminate solid TB cultures [5]. In contrast to
previous studies [4, 5, 7, 10, 11, 13], we prospectively col-
lected and split the sputum samples into two equal aliquots
which allowed a direct comparison between CPC treated
and non-CPC samples. Our study also extended sputum
sample storage with CPC beyond the usually reported
8 days [4, 10, 11, 13] to systematically investigate the CPC
storage time of 14 and 21 days. Finally, we also tested the
effect of CPC treatment on the performance of the mo-
lecular assay Xpert MTB/RIF.
Table 2 Effect of CPC incubation time on TB culture recovery
Culture grading (WHO) Non-CPC CPC incubation time
n (%) 7 days 14 days 21 days
Contaminated 9 (18) 6 (12) 6 (12) 3 (6)
Negative 8 (16) 2 (4) 1 (2) 6 (12)
Positive 33 (66) 42 (84) 43 (86) 41 (82)
< 20 colonies 0 (0) 3 (6) 4 (8) 3 (6)
1+ 3 (6) 7 (14) 7 (14) 7 (14)
2+ 10 (20) 13 (26) 13 (26) 15 (30)
3+ 20 (40) 19 (38) 19 (38) 16 (32)
Total 50 (100) 50 (100) 50 (100) 50 (100)
Decontamination time of 15 min for all CPC treated samples before
culture step
Difference between non-CPC and CPC incubation time (7, 14 and 21 days)
according to WHO culture grading (contaminated, negative, positive):
p = 0.077 across groups (Fisher’s exact test)
Culture results of 50 sputum samples not pretreated (non-CPC) or pretreated
with CPC before processing (CPC), with varying CPC incubation time of 7, 14,
and 21 days
Table 3 Effect of CPC pretreatment on the performance of
Xpert MTB/RIF












Xpert tests results of 100 samples treated with CPC
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The CPC treated samples showed higher culture recovery
and lower contamination compared to non-CPC samples,
with no negative effect on sample viability even when
stored at ambient temperature (25 °C) for up to 21 days.
Although TB culturing is resource-intensive and require
expensive laboratory facilities, TB cultures remain essential
for drug susceptibility testing, drug resistance surveillance
and molecular epidemiological studies [2, 3]. In our study,
15 min of sample decontamination with 1% NaOH yielded
optimal culture recovery, contamination, and culture nega-
tivity rates. CPC treated samples should be preferably
decontaminated using a lower NaOH concentration than
the NaOH concentration routinely used for decontamin-
ation (1% versus 1.5%) due to the weak decontaminating
properties of CPC [4, 11]. We observed that sputum sam-
ples stored with CPC as a preservation method can be
stored up to 21 days at room temperature in CPC without
reducing the culture recovery rate, consistent with the find-
ing from a previous study conducted in a region of the
former Soviet Union [4]. However, the latter study did not
systematically test the effect of storage time on culture
yield, but used a range of 7 to 36 days between sample
collection and processing.
Surprisingly, we did not observe a superior culture
recovery using the neutralizing Difco buffer compared to
the standard PBS buffer procedure. The Difco buffer
possibly neutralizes the weak anti-bacterial activity of
CPC, which might have a negative effect on the culture
yield. Our finding is in contrast to a previous study
which found that neutralization of CPC treated sputum
samples showed a higher culture yield compared to the
standard PBS procedure [7]. This difference might be
partially explained by the different sampling method
(random assignment to CPC or non-CPC treatment
versus splitting of sputum samples in our study), and the
different decontamination time used (10 min versus
15 min in our study) [7].
We did not observe a negative effect of CPC treatment
on the performance of the molecular test assay Xpert
MTB/RIF. Xpert is a semi-automated molecular assay
which detects both M. tuberculosis complex species and
rifampicin drug resistance [14]. It has been endorsed by
WHO and is currently being scaled-up in high TB inci-
dence countries [15]. Our results support the current
WHO guidelines for surveillance of drug resistance in
TB stating that sputum samples can also produce reli-
able results when tested using Xpert MTB/RIF even
after a month of CPC sputum sample storage [16]. Four
samples had a positive Xpert MTB/RIF results, but the
sputum cultures were either contaminated or negative.
However, as all samples were smear microscopy positive
they were likely to be Xpert MTB/RIF true positive. A
limitation of this analysis is that we performed Xpert
MTB/RIF on CPC treated sputum samples only.
Conclusion
In conclusion, in sub-Saharan African settings in which
sample collection sites can be distant from laboratories
CPC, can be used to preserve sample viability during
storage and transportation at ambient temperature for at
least 7 to as many as 21 days, with a high culture recov-
ery at an optimal decontamination time of 15 min. Fur-
thermore, CPC treated samples can also be used for
molecular analysis such as Xpert MTB/RIF. CPC can be
used at minimal costs (~0.01 USD per sample) as preser-
vative in sputum samples during transportation in hot
humid areas for laboratories and public health surveil-
lance, sample storage, transport using postal services,
and for drug resistance surveys. Unfortunately, CPC
treated sputum samples can only be cultured on solid
media, but not in liquid culture systems such as BAC-
TEC MGIT due to incompatibility with CPC [16, 17].
Future research should focus on the use of CPC or
other preservation methods [18] for the use in liquid
culture systems such as MIGT as a more sensitive cul-
ture detection and more standardized drug susceptibility
testing technique than solid culture media. Moreover,
addition of neutralizing buffer solutions after pretreat-
ment with CPC to increase culture recovery warrants
further exploration.
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